ID
31375
Description
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Keywords
Versions (2)
- 7/23/18 7/23/18 -
- 8/18/18 8/18/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 18, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
HAMA Results
- StudyEvent: ODM
Description
HAMA Results
Alias
- UMLS CUI-1
- C1291910
- UMLS CUI-2
- C1254595
Description
Human anti-mouse antibody; Specimen collection date
Data type
date
Alias
- UMLS CUI [1,1]
- C1291910
- UMLS CUI [1,2]
- C1302413
Description
Visit; Week
Data type
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0439230
Description
Visit; Week; Other
Data type
text
Alias
- UMLS CUI [1,1]
- C0545082C0439230
- UMLS CUI [1,2]
- C0205394
Description
HAMA Result
Data type
text
Alias
- UMLS CUI [1,1]
- C1291910
- UMLS CUI [1,2]
- C1254595
Similar models
HAMA Results
- StudyEvent: ODM
C1704732 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C1302413 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])